Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Scholar Rock Holding Corporation (SRRK : NSDQ)

• Company Description    Scholar Rock Holding Corporation is a biopharmaceutical company. It focused on the discovery and development of medicines for treatment of serious diseases. The company's product candidate includes SRK-015 and BMP6 which is in pre-clinical stage. Scholar Rock Holding Corporation is based in Cambridge, United States. Number of Employees: 196

• Price / Volume Information    Yesterday's Closing Price: $38.12 Daily Weekly Monthly 20 Day Moving Average: 1,320,227 shares Shares Outstanding: 94.95 (millions) Market Capitalization: $3,618.85 (millions) Beta: 0.33 52 Week High: $46.98 52 Week Low: $6.76 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 14.39% 10.11% 12 Week 23.95% 4.26% Year To Date -11.81% -17.41%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 301 BINNEY STREET 3RD FLOOR - CAMBRIDGE,MA 02142 USA ph: 857-259-3860 fax: 866-493-4935 ir@scholarrock.com http://www.scholarrock.com

• General Corporate Information    Officers Jay T. Backstrom - Chief Executive Officer and President David Hallal - Chairman of the Board of Directors Edward H. Myles - Chief Operating Officer & Chief Financial Officer Srinivas Akkaraju - Director Richard Brudnick - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 80706P103 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/25 Next Expected EPS Date: 08/14/25 Share - Related Items Shares Outstanding: 94.95 Most Recent Split Date: (:1) Beta: 0.33 Market Capitalization: $3,618.85 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.68 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-2.64 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 9.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/14/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 11.58 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: -13.56% vs. Previous Quarter: -11.67% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/25 - - 03/31/25 - -118.22 12/31/24 - -128.91 ROA 06/30/25 - - 03/31/25 - -82.01 12/31/24 - -85.80 Current Ratio 06/30/25 - - 03/31/25 - 10.25 12/31/24 - 9.61 Quick Ratio 06/30/25 - - 03/31/25 - 10.25 12/31/24 - 9.61 Operating Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Net Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Pre-Tax Margin 06/30/25 - - 03/31/25 - - 12/31/24 - - Book Value 06/30/25 - - 03/31/25 - 3.29 12/31/24 - 3.94 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - 0.16 12/31/24 - 0.14 Debt-to-Capital 06/30/25 - - 03/31/25 - 13.74 12/31/24 - 11.97

Powered by Zacks Investment Research ©